Ownership history in Alpha Wave Global, LP · 14 quarters on record
This page tracks every 13F SEC filing in which Alpha Wave Global, LP reported a position in AMYLYX PHARMACEUTICALS INC (AMLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 317,678 | -9,634 | -2.9% | 0.47% | $3.8M | $12.08 |
| 2025 Q3 | ADDED | 327,312 | +51,470 | +18.7% | 0.45% | $4.4M | $13.59 |
| 2025 Q2 | ADDED | 275,842 | +88,531 | +47.3% | 0.19% | $1.8M | $6.41 |
| 2025 Q1 | ADDED | 187,311 | +38,684 | +26.0% | 0.30% | $663K | $3.54 |
| 2024 Q4 | REDUCED | 148,627 | -520,860 | -77.8% | 0.26% | $562K | $3.78 |
| 2024 Q3 | REDUCED | 669,487 | -176,753 | -20.9% | 0.67% | $2.2M | $3.24 |
| 2023 Q4 | REDUCED | 846,240 | -7,022 | -0.8% | 6.01% | $12.5M | $14.72 |
| 2023 Q3 | UNCHANGED | 853,262 | — | 0% | 9.88% | $15.62B | $18.31 |
| 2023 Q2 | REDUCED | 853,262 | -77,075 | -8.3% | 12.06% | $18.4M | $21.57 |
| 2023 Q1 | ADDED | 930,337 | +109,117 | +13.3% | 10.08% | $27.3M | $29.34 |
As of 2025 Q4 — sorted by position size